Of interest, the activity of beta-glucocerebrosidase, a sphingolipid-metabolizing enzyme, was impaired in FTD phenotypic Grn−/− mice and FTD patients carrying GRN mutations [119]. This evidence concerns the gene GRN and frontotemporal dementia.